Showing results (1281-1290 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|August 16, 2002
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donorsN Kröger, T Zabelina, W Krüger, et al.
Bone Marrow Transplantation|August 16, 2002
Invasive airway aspergillosis with new airflow obstruction mimicking post-BMT bronchiolitis obliteransS Nusair, G Amir, R Or, et al.
Bone Marrow Transplantation|August 22, 2002
Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapyC P Anderson, C P Reynolds
Bone Marrow Transplantation|August 22, 2002
The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivoZ Hassan, E Hellström-Lindberg, S Alsadi, et al.
Bone Marrow Transplantation|August 22, 2002
High-dose chemotherapy as salvage treatment for seminomaO Rick, W Siegert, N Schwella, et al.
Bone Marrow Transplantation|August 22, 2002
Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host diseaseS Kumar, R C Wolf, M G Chen, et al.
Bone Marrow Transplantation|August 22, 2002
Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantationH Hebart, T Rudolph, J Loeffler, et al.
Bone Marrow Transplantation|August 22, 2002
Successful allogeneic blood stem cell transplantation for aplastic anemia in a patient with renal insufficiency requiring dialysisT Hamaki, H Katori, M Kami, et al.
Bone Marrow Transplantation|August 31, 2002
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)O N Koç, J Day, M Nieder, et al.
Bone Marrow Transplantation|August 31, 2002
High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantationR Nakamura, K Cortez, S Solomon, et al.
Pageof 993